| The polycomb group protein EZH2 is involved in progression of prostate cancer S Varambally, SM Dhanasekaran, M Zhou, TR Barrette, C Kumar-Sinha, ... Nature 419 (6907), 624-629, 2002 | 3348 | 2002 |
| The International Society of Urological Pathology (ISUP) vancouver classification of renal neoplasia JR Srigley, B Delahunt, JN Eble, L Egevad, JI Epstein, D Grignon, O Hes, ... The American journal of surgical pathology 37 (10), 1469-1489, 2013 | 1273 | 2013 |
| α-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer MA Rubin, M Zhou, SM Dhanasekaran, S Varambally, TR Barrette, ... Jama 287 (13), 1662-1670, 2002 | 908 | 2002 |
| Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program RB Shah, R Mehra, AM Chinnaiyan, R Shen, D Ghosh, M Zhou, ... Cancer research 64 (24), 9209-9216, 2004 | 746 | 2004 |
| Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study P Ström, K Kartasalo, H Olsson, L Solorzano, B Delahunt, DM Berney, ... The Lancet Oncology 21 (2), 222-232, 2020 | 568 | 2020 |
| Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis MA Rubin, B Kleter, M Zhou, G Ayala, AL Cubilla, WGV Quint, EC Pirog The American journal of pathology 159 (4), 1211-1218, 2001 | 562 | 2001 |
| Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma TK Choueiri, A Plantade, P Elson, S Negrier, A Ravaud, S Oudard, ... Journal of Clinical Oncology 26 (1), 127-131, 2008 | 500 | 2008 |
| Changes in cerebral cortex size are governed by fibroblast growth factor during embryogenesis FM Vaccarino, ML Schwartz, R Raballo, J Nilsen, J Rhee, M Zhou, ... Nature neuroscience 2 (3), 246-253, 1999 | 499 | 1999 |
| Interleukin-8 mediates resistance to antiangiogenic agent sunitinib in renal cell carcinoma D Huang, Y Ding, M Zhou, BI Rini, D Petillo, CN Qian, R Kahnoski, ... Cancer research 70 (3), 1063-1071, 2010 | 483 | 2010 |
| Fibroblast growth factor 2 control of vascular tone M Zhou, RL Sutliff, RJ Paul, JN Lorenz, JB Hoying, CC Haudenschild, ... Nature medicine 4 (2), 201-207, 1998 | 474 | 1998 |
| Pathological findings in the testes of COVID-19 patients: clinical implications M Yang, S Chen, BO Huang, JM Zhong, H Su, YJ Chen, Q Cao, L Ma, ... European urology focus 6 (5), 1124-1129, 2020 | 473 | 2020 |
| An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma A Ooi, JC Wong, D Petillo, D Roossien, V Perrier-Trudova, D Whitten, ... Cancer cell 20 (4), 511-523, 2011 | 439 | 2011 |
| Renal mass biopsy—a renaissance? BR Lane, MK Samplaski, BR Herts, M Zhou, AC Novick, SC Campbell The Journal of urology 179 (1), 20-27, 2008 | 405 | 2008 |
| Alpha-Methylacyl-CoA racemase: a novel tumor marker over-expressed in several human cancers and their precursor lesions M Zhou, AM Chinnaiyan, CG Kleer, PC Lucas, MA Rubin The American journal of surgical pathology 26 (7), 926-931, 2002 | 385 | 2002 |
| TMPRSS2–ERG gene fusion prevalence and class are significantly different in prostate cancer of caucasian, african‐american and japanese patients C Magi‐Galluzzi, T Tsusuki, P Elson, K Simmerman, C LaFargue, ... The Prostate 71 (5), 489-497, 2011 | 331 | 2011 |
| Renal angiomyolipoma: clinicopathologic study of 194 cases with emphasis on the epithelioid histology and tuberous sclerosis association H Aydin, C Magi-Galluzzi, BR Lane, L Sercia, JI Lopez, BI Rini, M Zhou The American journal of surgical pathology 33 (2), 289-297, 2009 | 322 | 2009 |
| Comparison of the basal cell-specific markers, 34βE12 and p63, in the diagnosis of prostate cancer RB Shah, M Zhou, M LeBlanc, M Snyder, MA Rubin The American journal of surgical pathology 26 (9), 1161-1168, 2002 | 311 | 2002 |
| A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy BR Lane, D Babineau, MW Kattan, AC Novick, IS Gill, M Zhou, CJ Weight, ... The Journal of urology 178 (2), 429-434, 2007 | 297 | 2007 |
| Renal epithelioid angiomyolipoma with atypia: a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy F Brimo, B Robinson, C Guo, M Zhou, M Latour, JI Epstein The American journal of surgical pathology 34 (5), 715-722, 2010 | 288 | 2010 |
| Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor–targeted therapy AR Golshayan, S George, DY Heng, P Elson, LS Wood, TM Mekhail, ... Journal of Clinical Oncology 27 (2), 235-241, 2009 | 282 | 2009 |
